Protara Therapeutics (TARA) Treasury Shares (2013 - 2025)
Protara Therapeutics (TARA) posted quarterly Treasury Shares of $571145.0 for Q4 2025, up 93.01% year-over-year from $295914.0 in Q4 2024, and up 2.86% quarter-over-quarter from $555245.0 in Q3 2025.
Protara Therapeutics (TARA) Treasury Shares (2013 - 2025) Analysis & Trends
Protara Therapeutics (TARA) has reported Treasury Shares for 6 consecutive years, with $571145.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Treasury Shares rose 93.01% year-over-year to $571145.0; the TTM figure through Dec 2025 stood at $571145.0 (up 93.01% YoY), while the FY2025 annual figure was $571145.0, up 93.01% from the prior year.
- Treasury Shares grew to $571145.0 in Q4 2025 per TARA's latest filing, from $555245.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $571145.0 in Q4 2025 and bottomed at $196838.0 in Q4 2022.
- Historically, Treasury Shares has averaged $368608.2 across 4 years, with a median of $319404.5 in 2024.
- On a YoY basis, Treasury Shares climbed as much as 93.01% in 2025 and fell as far as 12.16% in 2025.
- Protara Therapeutics' Treasury Shares stood at $196838.0 in 2022, then grew by 20.24% to $236679.0 in 2023, then advanced by 25.03% to $295914.0 in 2024, then surged by 93.01% to $571145.0 in 2025.
- Business Quant data shows TARA's Treasury Shares at $571145.0 in Q4 2025, $555245.0 in Q3 2025, and $510945.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Protara Therapeutics | 234.56 Mn | 234.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 571,145.00 |
| Dec 31, 2025 | 571,145.00 |
| Sep 30, 2025 | 555,245.00 |
| Sep 30, 2025 | 555,245.00 |
| Jun 30, 2025 | 510,945.00 |
| Jun 30, 2025 | 510,945.00 |
| Mar 31, 2025 | 384,593.00 |
| Mar 31, 2025 | 384,593.00 |
| Dec 31, 2024 | 295,914.00 |
| Dec 31, 2024 | 295,914.00 |
| Sep 30, 2024 | 295,914.00 |
| Sep 30, 2024 | 295,914.00 |
| Jun 30, 2024 | 295,914.00 |
| Jun 30, 2024 | 295,914.00 |
| Mar 31, 2024 | 342,895.00 |
| Mar 31, 2024 | 342,895.00 |
| Dec 31, 2023 | 236,679.00 |
| Dec 31, 2023 | 236,679.00 |
| Dec 31, 2022 | 196,838.00 |
| Dec 31, 2022 | 196,838.00 |